BIGG

Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

Wedzicha, JA; Calverley, PMA; Albert, RK; Anzueto, A; Criner, GJ; Hurst, JR; Miravitlles, M; Papi, A; Rabe, KF; Rigau, D; Sliwinski, P; Tonia, T; Vestbo, J; Wilson, KC; Krishnan, JA.

Eur. respir. j; 50 (3), 2017

This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...

Agonistas de Receptores Adrenérgicos beta 2/uso terapéutico, Aminopiridinas/uso terapéutico, Benzamidas/uso terapéutico, Ciclopropanos/uso terapéutico, Fluoroquinolonas/uso terapéutico, Macrólidos/uso terapéutico, Antagonistas Muscarínicos/uso terapéutico, Inhibidores de Fosfodiesterasa 4/uso terapéutico, Progresión de la Enfermedad, Enfermedad Pulmonar Obstructiva Crónica, Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico, Enfermedad Pulmonar Obstructiva Crónica/fisiopatología, Prevención Secundaria/normas, Agonistas de Receptores Adrenérgicos beta 2, Aminopiridinas, Benzamidas, Ciclopropanos, Fluoroquinolonas, Macrólidos, Antagonistas Muscarínicos, Inhibidores de Fosfodiesterasa 4

Texto completo

Diagnosis and Management of Community-Acquired Pneumonia in Adults

Community-acquired pneumonia is diagnosed by clinical features (e.g., cough, fever, pleuritic chest pain) and by lung imaging, usually an infiltrate seen on chest radiography. Initial evaluation should determine the need for hospitalization versus outpatient management using validated mortality or severi...